Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - BioMed Realty Trust Inc | a55933exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 22, 2010
BioMed Realty Trust, Inc.
(Exact name of registrant as specified in its charter)
Maryland | 1-32261 | 20-1142292 | ||
(State or Other Jurisdiction | (Commission File No.) | (I.R.S. Employer | ||
of | Identification No.) | |||
Incorporation) |
17190 Bernardo Center Drive
San Diego, California 92128
(Address of principal executive offices, including zip code)
San Diego, California 92128
(Address of principal executive offices, including zip code)
Registrants telephone number, including area code: (858) 485-9840
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 8.01 Other Events.
On April 22, 2010, BioMed Realty Trust, Inc. announced that its operating partnership
subsidiary, BioMed Realty, L.P., priced the private placement of $250,000,000 aggregate principal
amount of 6.125% Senior Notes due 2020. The press release announcing the pricing of this private
placement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by
reference.
Item 9.01 Financial Statements and Exhibits.
(d) The following exhibits are filed herewith:
Exhibit | ||
Number | Description of Exhibit | |
99.1
|
Press release issued by BioMed Realty Trust, Inc. on April 22, 2010. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 28, 2010 | BIOMED REALTY TRUST, INC. |
|||
By: | /s/ KENT GRIFFIN | |||
Name: | Kent Griffin | |||
Title: | President, Chief Operating Officer and Chief Financial Officer |
Exhibit Index
Exhibit | ||
Number | Description of Exhibit | |
99.1
|
Press release issued by BioMed Realty Trust, Inc. on April 22, 2010. |